1. Home
  2. ORKA vs WDH Comparison

ORKA vs WDH Comparison

Compare ORKA & WDH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ORKA
  • WDH
  • Stock Information
  • Founded
  • ORKA 2004
  • WDH 2016
  • Country
  • ORKA United States
  • WDH China
  • Employees
  • ORKA N/A
  • WDH N/A
  • Industry
  • ORKA Biotechnology: In Vitro & In Vivo Diagnostic Substances
  • WDH Specialty Insurers
  • Sector
  • ORKA Health Care
  • WDH Finance
  • Exchange
  • ORKA Nasdaq
  • WDH Nasdaq
  • Market Cap
  • ORKA 580.3M
  • WDH 651.0M
  • IPO Year
  • ORKA N/A
  • WDH 2021
  • Fundamental
  • Price
  • ORKA $15.44
  • WDH $1.84
  • Analyst Decision
  • ORKA Strong Buy
  • WDH
  • Analyst Count
  • ORKA 9
  • WDH 0
  • Target Price
  • ORKA $40.38
  • WDH N/A
  • AVG Volume (30 Days)
  • ORKA 142.1K
  • WDH 278.4K
  • Earning Date
  • ORKA 08-11-2025
  • WDH 09-04-2025
  • Dividend Yield
  • ORKA N/A
  • WDH 2.21%
  • EPS Growth
  • ORKA N/A
  • WDH 118.23
  • EPS
  • ORKA N/A
  • WDH 0.15
  • Revenue
  • ORKA N/A
  • WDH $388,729,415.00
  • Revenue This Year
  • ORKA N/A
  • WDH N/A
  • Revenue Next Year
  • ORKA N/A
  • WDH $9.29
  • P/E Ratio
  • ORKA N/A
  • WDH $11.81
  • Revenue Growth
  • ORKA N/A
  • WDH 3.35
  • 52 Week Low
  • ORKA $5.49
  • WDH $0.97
  • 52 Week High
  • ORKA $52.32
  • WDH $2.17
  • Technical
  • Relative Strength Index (RSI)
  • ORKA 59.14
  • WDH 58.63
  • Support Level
  • ORKA $14.10
  • WDH $1.76
  • Resistance Level
  • ORKA $15.76
  • WDH $1.86
  • Average True Range (ATR)
  • ORKA 1.12
  • WDH 0.07
  • MACD
  • ORKA 0.04
  • WDH -0.01
  • Stochastic Oscillator
  • ORKA 83.71
  • WDH 65.83

About ORKA Oruka Therapeutics Inc. Common Stock

Oruka Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing novel monoclonal antibody therapeutics for psoriasis (PsO) and other inflammatory and immunology (I&I) indications. Its lead program, ORKA-001, is designed to target the p19 subunit of interleukin-23 (IL-23p19) for the treatment of PsO. The company's co-lead program, ORKA-002, is designed to target interleukin-17A and interleukin-17F (IL-17A/F) for the treatment of PsO, psoriatic arthritis (PsA), and other conditions. These programs each bind their respective targets at high affinity and incorporate half-life extension technology to increase exposure and decreasing dosing frequency.

About WDH Waterdrop Inc. (each representing the right to receive 10)

Waterdrop Inc is a technology platform dedicated to insurance and healthcare service. The Company is mainly engaged in operating an independent third-party insurance platform dedicated to providing insurance and healthcare service. The Company's main businesses are the insurance marketplace, medical crowdfunding, and mutual aid. The insurance marketplace business is collaborated with insurance carriers to offer health and life insurance products to ensure a smooth and friendly user experience throughout the process from underwriting to claim services. The medical crowdfunding business enabled people with medical costs.

Share on Social Networks: